TVM Capital Life Science
TVM Capital Life Science is an international venture capital firm with a transatlantic team that invests in life science innovations, focusing on both early-stage therapeutics and late-stage de-risked biopharma and medical devices.
Funder analysis
Web-researched analysis· 25 Jul 2026· v6-nodomain-3Investment thesis
TVM employs a dual-pronged strategy combining late-stage de-risked biopharma and medical device products with early-stage therapeutics to generate attractive venture returns. The firm focuses on funding novel, disruptive life science innovations that have the potential to transform medical practice and improve patient outcomes.
Value add
expertise, teamwork framework, capital and time efficiencies
Portfolio focus
therapeutics and medical technologies, commercial-stage medtech, diagnostics, digital health, late-stage therapeutics, early-stage therapeutics
Sources
3 more sources
Co-investors
No co-investors named in this fund's research yet.